These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 317422)

  • 21. Levamisole-mediated restoration of cellular immunity in peripheral blood lymphocytes of patients with immunodeficiency diseases.
    Lieberman R; Hsu M
    Clin Immunol Immunopathol; 1976 Jan; 5(1):142-6. PubMed ID: 1261096
    [No Abstract]   [Full Text] [Related]  

  • 22. Levamisole as an immunopotentiator for T cell deficiency.
    Taki HN; Schwartz SA
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):129-37. PubMed ID: 8077602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunotherapy with levamisole in sepsis in newborn infants].
    Isakov IuF; Samsygin SA; Dolgina EN; Mortina SV
    Vestn Akad Med Nauk SSSR; 1983; (4):57-61. PubMed ID: 6603078
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 25. Levamisole and cellular immunity in rheumatoid arthritis--a review.
    Mowat AG
    J Rheumatol Suppl; 1978; 4():55-61. PubMed ID: 366144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levamisole.
    Beatty DW
    S Afr Med J; 1978 Jan; 53(3):73-4. PubMed ID: 306687
    [No Abstract]   [Full Text] [Related]  

  • 27. [Letter: Crohn's disease and levamisole].
    Bertrand J; Renoux G; Renoux M; Palat A
    Nouv Presse Med; 1974 Oct; 3(35):2265. PubMed ID: 4617861
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of isolated cellular immune defect with transfer factor (author's transl)].
    Göring HD; Fiehring C; Schröder I
    Dermatol Monatsschr; 1980 Feb; 166(2):81-7. PubMed ID: 6967428
    [No Abstract]   [Full Text] [Related]  

  • 29. [Principle of immunoregulation in the treatment of chronic inflammatory rheumatism].
    Duţu A; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(3):193-203. PubMed ID: 6084276
    [No Abstract]   [Full Text] [Related]  

  • 30. A hypothesis. The mechanism of action of levamisole: immune restoration through enhanced cell maturation.
    Amery WK
    J Reticuloendothel Soc; 1978 Aug; 24(2):187-93. PubMed ID: 309007
    [No Abstract]   [Full Text] [Related]  

  • 31. [Levamisole - a new immunostimulant].
    Rachkov SM
    Ter Arkh; 1976; 48(11):133-8. PubMed ID: 1088219
    [No Abstract]   [Full Text] [Related]  

  • 32. [Levamisole as an immunostimulating factor].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1979; 8():56-62. PubMed ID: 318115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic disorders in endogenous uveitis and the possible means of their correction by drugs].
    Vanichkin AA; Shpak NI
    Oftalmol Zh; 1982; 37(1):10-3. PubMed ID: 6979018
    [No Abstract]   [Full Text] [Related]  

  • 34. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cellular immunity in burns (literature survey)].
    Panchenkov NR
    Probl Gematol Pereliv Krovi; 1976; 21(9):37-40. PubMed ID: 794870
    [No Abstract]   [Full Text] [Related]  

  • 36. [Levamisole and rheumatoid arthritis].
    Cats A
    Ned Tijdschr Geneeskd; 1980 Apr; 124(14):508-11. PubMed ID: 6966379
    [No Abstract]   [Full Text] [Related]  

  • 37. Fractions of middle molecular weight responsible for immunodeficiency in malnourished and burnt patients.
    Gay G; Touraine JL; Touraine F; Freyria AM; Traeger J; Navarro J
    Artif Organs; 1981; 4 Suppl():71-5. PubMed ID: 6794551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levamisole treatment experience with infectious allergic bronchial asthma].
    Provotorov VM; Nikitin AV; Buravleva IV
    Klin Med (Mosk); 1981 Apr; 59(4):13-8. PubMed ID: 6972464
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.